Fatigue was not reported as a common side effect in clinical trials for Mounjaro, which is the same molecule, tirzepatide, but approved for weight loss peptide therapy in the context of type 2 diabetes management
But could they actually work together in a synergistic way, ecreating the ideal state of being calm yet energized
It should be a gentle trickle, not a jet stream
Phase I and II clinical trials conducted have shown improved cognitive and motor function with different drugs from GLP-1RA group although the small sized and limited duration of trials have not provided a conclusive result to influence the practice, although with further advancement in ongoing trials effects observed may be noteworthy for intervention in future practice (119)
Summary: GLP-1 stands for Glucagon-Like Peptide-1, a hormone produced in the small intestine that regulates blood glucose and appetite
Clinical and observational research has shown that GLP-1 medications are associated with reduced alcohol cravings, lower consumption, and decreased risk of alcohol-related disorders GLP-1 use is already widespread in the U.S